These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7923310

  • 1. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W.
    Clin Ther; 1994; 16(3):437-45. PubMed ID: 7923310
    [Abstract] [Full Text] [Related]

  • 2. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A, Fidalgo P, Freire A, Matos L.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [Abstract] [Full Text] [Related]

  • 3. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB.
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [Abstract] [Full Text] [Related]

  • 4. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A, Tzivras M, Fertakis A, Emmanuel A, Laoudi F, Kalantzis N, Anthopoulou H, Michailidis D.
    Clin Ther; 1992 Mar; 14(4):553-61. PubMed ID: 1525789
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F, Minieri M, Manzi G, Piai G, D'Angelo V, Mazzacca G.
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [Abstract] [Full Text] [Related]

  • 6. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
    Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H.
    Clin Ther; 1987 Jan; 10(1):44-51. PubMed ID: 3329964
    [Abstract] [Full Text] [Related]

  • 7. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F, Staub P, Hammer B, Guyot J, Miazza BM.
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [Abstract] [Full Text] [Related]

  • 8. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN, Archambault A.
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [Abstract] [Full Text] [Related]

  • 9. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
    De Nutte N, Van Ganse W, Witterhulghe M, Defrance P.
    Clin Ther; 1989 Mar; 11(1):62-8. PubMed ID: 2655906
    [Abstract] [Full Text] [Related]

  • 10. [The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].
    Gundermann KJ, Godehardt E, Ulbrich M.
    MMW Fortschr Med; 2004 Aug 05; 146 Suppl 2():71-6. PubMed ID: 16739362
    [Abstract] [Full Text] [Related]

  • 11. Prokinetic drug treatment (cisapride) is as effective as H2-blocking agent (ranitidine) in the treatment of gastric ulcer.
    Simon B, Bergemann W, Bouzo H, Hüttemann W, Hotz F, Müller P, Rösch W.
    Hepatogastroenterology; 1991 Dec 05; 38 Suppl 1():41-5. PubMed ID: 1823066
    [Abstract] [Full Text] [Related]

  • 12. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.
    Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910
    [Abstract] [Full Text] [Related]

  • 13. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W, Vinson B, Sassin I.
    Z Gastroenterol; 2002 Jun 01; 40(6):401-8. PubMed ID: 12055663
    [Abstract] [Full Text] [Related]

  • 14. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial.
    Fumagalli I, Hammer B.
    Scand J Gastroenterol; 1994 Jan 01; 29(1):33-7. PubMed ID: 8128175
    [Abstract] [Full Text] [Related]

  • 15. [A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia].
    Wang B, Liang X, Jia B.
    Zhonghua Nei Ke Za Zhi; 1995 Mar 01; 34(3):180-4. PubMed ID: 7648940
    [Abstract] [Full Text] [Related]

  • 16. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms].
    Fehr HF.
    Schweiz Med Wochenschr; 1991 Jun 01; 121(22):843-6. PubMed ID: 2063165
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
    Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, Escobedo S, Lee J, Sinclair P.
    Am J Gastroenterol; 2005 Jul 01; 100(7):1477-88. PubMed ID: 15984968
    [Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
    Kato M, Watanabe M, Konishi S, Kudo M, Konno J, Meguro T, Kitamori S, Nakagawa S, Shimizu Y, Takeda H, Asaka M.
    Aliment Pharmacol Ther; 2005 Jun 01; 21 Suppl 2():27-31. PubMed ID: 15943843
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia.
    al-Quorain A, Larbi EB, al-Shedoki F.
    Scand J Gastroenterol; 1995 Jun 01; 30(6):531-4. PubMed ID: 7569759
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting dose selection and outcome of cisapride treatment for dyspepsia in primary care. The Austro-Cis Study Group.
    Brunner H.
    Aliment Pharmacol Ther; 1996 Aug 01; 10(4):587-94. PubMed ID: 8853763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.